Our partner Diacron has the most comprehensive panel (Panel Carratelli) for global assessment and diagnosis of oxidative balance applicable to many...
AFS Bio has partnered up with Primer Design (A Novacyt Group Company)âŻto support the scientific community's testing efforts.âŻÂ
Â
Primer Design is a...
AFSBio is excited to introduce the Petaka G3 from Celartia. Today we are showcasing its relevance in supporting biomanufacturing of cell therapies....
At AFSBio, our goal is to help researchers achieve higher quality experimental conditions so they can publish papers of higher relevancy â arriving first at solutions they can publish or patent. With our carefully ...
What is oxidative stress Oxidative stress in a living organism is a chemical condition in which oxidative species overcome antioxidant systems due ...
Researchers who regularly perform cell culture are likely familiar with the process of trypsinization. A trypsinization protocol is used for cel...
Application of single-cell sequencing in human cancer Mattias Rantalainen Briefings in Functional Genomics, Vo...
Introduction It is reported that the annual loss in biological and medical research caused by antibodies of inferior quality amounts to approximate...
The need for a simple, fast, yet sensitive diagnostic, screening, and molecular characterization tool is indispensable in clinical and research app...
Our partner Diacron has the most comprehensive panel (Panel Carratelli) for global assessment and diagnosis of oxidative balance applicable to many...
We are excited to introduce to you a silica nanoparticle technology from our partners AcZon. AcZon designed these silica nanoparticles with hopes o...
 Our partner Lena Biosciences has created a novel approach to a 3D Perfused organ-on-a-chip model. In the following paper, they demonstrate how th...
AFS Bio has partnered up with Primer Design (A Novacyt Group Company)âŻto support the scientific community's testing efforts.âŻÂ  Primer Design is a...
AFSBio is excited to introduce the Petaka G3 from Celartia. Today we are showcasing its relevance in supporting biomanufacturing of cell therapies....
AFSBio is proud to announce the beginning of a new distribution agreement with CALIXAR. Â Under this agreement, AFSBio will promote and distri...
At AFSBio, our goal is to help researchers achieve higher quality experimental conditions so they can publish papers of higher relevancy â arriving first at solutions they can publish or patent. With our carefully ...
